15-41504555-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002344.6(LTK):c.2206G>A(p.Val736Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002344.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTK | NM_002344.6 | c.2206G>A | p.Val736Ile | missense_variant | 18/20 | ENST00000263800.11 | NP_002335.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTK | ENST00000263800.11 | c.2206G>A | p.Val736Ile | missense_variant | 18/20 | 1 | NM_002344.6 | ENSP00000263800.6 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000116 AC: 29AN: 250958Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135674
GnomAD4 exome AF: 0.000122 AC: 178AN: 1461554Hom.: 0 Cov.: 34 AF XY: 0.000138 AC XY: 100AN XY: 727096
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.2206G>A (p.V736I) alteration is located in exon 18 (coding exon 18) of the LTK gene. This alteration results from a G to A substitution at nucleotide position 2206, causing the valine (V) at amino acid position 736 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at